CopyFind
Grampod 200mg Tablet
medicine 📍 IN

Grampod 200mg Tablet

298,00 ₹

Analogs of Grampod 200mg Tablet

Find cheaper analogs and generic equivalents for Grampod 200mg Tablet.

Ingredients

Substancja czynna: Cefpodoxime Proxetil


Przegląd produktu

About Grampod

Grampod is a medication containing the active ingredient Cefpodoxime Proxetil, classified as Antibiotic. Cefpodoxime is an oral, third-generation cephalosporin antibiotic available in various generic preparations. It is active against both Gram-positive and Gram-negative organisms with notable exceptions including Pseudomonas aeruginosa, Enterococcus, and Bacteroides fragilis.

Key Benefits & Uses

  • Used for: INDICATIONS AND USAGE Cefpodoxime proxetil is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains.
  • Used for: Recommended dosages, durations of therapy, and applicable patient populations vary among these infections
  • Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Cefpodoxime Proxetil, the active ingredient in Grampod, belongs to the Antibiotic class. INDICATIONS AND USAGE Cefpodoxime proxetil is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below. Recommended dosages, durations of therapy, and applicable patient populations vary among these infections. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Grampod. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Grampod for extended periods without medical advice.

Find in Pharmacies

Compare local prices and distance for Grampod 200mg Tablet.

Visitor ratings

Help others by rating how useful this product page is.

No ratings yet — be the first.